Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1990 2
1991 2
1992 2
1993 2
1996 3
1997 4
1998 8
1999 3
2000 6
2001 1
2002 2
2007 1
2008 1
2009 2
2013 1
2016 2
2017 4
2018 4
2020 1
2021 4
2022 5
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
A Multicenter, Single-Blind, Randomized, Warfarin-Controlled Trial of Edoxaban in Patients With Chronic Thromboembolic Pulmonary Hypertension: KABUKI Trial.
Hosokawa K, Watanabe H, Taniguchi Y, Ikeda N, Inami T, Yasuda S, Murohara T, Hatano M, Tamura Y, Yamashita J, Tatsumi K, Tsujino I, Kobayakawa Y, Adachi S, Yaoita N, Minatsuki S, Todaka K, Fukuda K, Tsutsui H, Abe K; KABUKI Investigators. Hosokawa K, et al. Among authors: todaka k. Circulation. 2024 Jan 30;149(5):406-409. doi: 10.1161/CIRCULATIONAHA.123.067528. Epub 2023 Nov 13. Circulation. 2024. PMID: 37956127 Free PMC article. Clinical Trial. No abstract available.
Long-term outcome of chronic thromboembolic pulmonary hypertension using direct oral anticoagulants and warfarin: a Japanese prospective cohort study.
Hosokawa K, Abe K, Funakoshi K, Tamura Y, Nakashima N, Todaka K, Taniguchi Y, Inami T, Adachi S, Tsujino I, Yamashita J, Minatsuki S, Ikeda N, Shimokawahara H, Kawakami T, Ogo T, Hatano M, Ogino H, Fukumoto Y, Tanabe N, Matsubara H, Fukuda K, Tatsumi K, Tsutsui H. Hosokawa K, et al. Among authors: todaka k. J Thromb Haemost. 2023 Aug;21(8):2151-2162. doi: 10.1016/j.jtha.2023.03.036. Epub 2023 Apr 10. J Thromb Haemost. 2023. PMID: 37044277
Efficacy and safety of edoxaban in patients with chronic thromboembolic pulmonary hypertension: protocol for a multicentre, randomised, warfarin-controlled, parallel group trial - KABUKI trial.
Hosokawa K, Abe K, Kishimoto J, Kobayakawa Y, Todaka K, Tamura Y, Tatsumi K, Inami T, Ikeda N, Taniguchi Y, Minatsuki S, Murohara T, Yasuda S, Fukuda K, Tsutsui H. Hosokawa K, et al. Among authors: todaka k. BMJ Open. 2022 Jul 19;12(7):e061225. doi: 10.1136/bmjopen-2022-061225. BMJ Open. 2022. PMID: 37070473 Free PMC article.
Safety, Tolerability, and Pharmacokinetics of NK-104-NP.
Nakano K, Matoba T, Koga JI, Kashihara Y, Fukae M, Ieiri I, Shiramoto M, Irie S, Kishimoto J, Todaka K, Egashira K. Nakano K, et al. Among authors: todaka k. Int Heart J. 2018 Sep 26;59(5):1015-1025. doi: 10.1536/ihj.17-555. Epub 2018 Aug 29. Int Heart J. 2018. PMID: 30158384 Free article. Clinical Trial.
Deep Learning of ECG for the Prediction of Postoperative Atrial Fibrillation.
Tohyama T, Ide T, Ikeda M, Nagata T, Tagawa K, Hirose M, Funakoshi K, Sakamoto K, Kishimoto J, Todaka K, Nakashima N, Tsutsui H. Tohyama T, et al. Among authors: todaka k. Circ Arrhythm Electrophysiol. 2023 Feb;16(2):e011579. doi: 10.1161/CIRCEP.122.011579. Epub 2023 Jan 30. Circ Arrhythm Electrophysiol. 2023. PMID: 36716179 No abstract available.
Survey Results and Recommendations from Japanese Stakeholders for Good Clinical Practice Renovation.
Nakamura K, Ozawa H, Shibata T, Ushirozawa N, Hata T, Okita N, Fuse N, Sato N, Ikeda K, Hanaoka H, Maruyama T, Wada M, Shimizu S, Kasai H, Yamamoto Y, Sakurai J, Todaka K, Tashiro S, Yamamoto H. Nakamura K, et al. Among authors: todaka k. Ther Innov Regul Sci. 2022 Mar;56(2):220-229. doi: 10.1007/s43441-021-00350-4. Epub 2021 Nov 17. Ther Innov Regul Sci. 2022. PMID: 34787814 Free PMC article.
A novel quantitative indicator for disease progression rate in amyotrophic lateral sclerosis.
Kobayakawa Y, Todaka K, Hashimoto Y, Ko S, Shiraishi W, Kishimoto J, Kira JI, Yamasaki R, Isobe N; Pooled Resource Open-Access ALS Clinical Trials Consortium. Kobayakawa Y, et al. Among authors: todaka k. J Neurol Sci. 2022 Nov 15;442:120389. doi: 10.1016/j.jns.2022.120389. Epub 2022 Aug 24. J Neurol Sci. 2022. PMID: 36041329 Free article.
Clinical significance of polyglutamylation in primary central nervous system lymphoma.
Shinojima N, Fujimoto K, Makino K, Todaka K, Yamada K, Mikami Y, Oda K, Nakamura K, Jono H, Kuratsu JI, Nakamura H, Yano S, Mukasa A. Shinojima N, et al. Among authors: todaka k. Acta Neuropathol Commun. 2018 Feb 23;6(1):15. doi: 10.1186/s40478-018-0522-4. Acta Neuropathol Commun. 2018. PMID: 29475458 Free PMC article.
65 results